Lilly’s Cymbalta Wins FDA Approval For Major Depression Maintenance Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
The battle with Wyeth’s competing SNRI Effexor XR for new indications continues; Cymbalta could see an indication for fibromyalgia in 2008.